Pioneering Egypt’s Cosmeceuticals Industry

MCRO.CA

Share Price

EGP 3.03 /Share

-3.19%

High:EGP 3.18
Low:EGP 3.00
Open:EGP 3.13
Close:EGP 3.03

Last trade 30/03/2022 14:28:PM
Data delayed 15-20 min

Details

With an almost two-decade presence in Egypt, Macro Group Pharmaceuticals is a pioneer and market-leader in the country’s cosmeceutical space. The company has steadily grown in size to lead the highly fragmented market in terms of sales by catering to multiple demographic segments with a well-developed portfolio of products diversified across 7 high-growth therapeutic areas within cosmeceuticals and 1 newly added therapeutic area under nutraceuticals.

Read More

Highlights

  • 8

    Therapeutic Areas
    FY21

  • 119 SKUs

    Portfolio Size
    FY21

  • 24%/1st

    Market Share/Rank
    FY21

Consolidated Financials 2018-20

PDF - Download

Our Strategy

With a clear and well-articulated growth strategy underpinned by a number of expansion pillars, Macro Group has set in motion a number of growth avenues with the ultimate objective to develop its brand equity, increase its top line, and enhance its margins:

  • Enhance current portfolio and increase penetration of large and fast growing therapeutic areas
  • Offer products at attractive price points with higher margins, capturing larger market shares
  • Diversify portfolio by expanding into new segments
  • Direct to consumer (“DTC”) market development strategy and e-commerce initiatives
  • Inorganic expansion

EVENTS

1Q22 Results Call
31 May 2022